ASTRAZENECA ANNUAL REVIEW 2006 BOARD OF DIRECTORS LOUIS SCHWEITZER 64 DAVID R BRENNAN 53 JONATHAN SYMONDS CBE 47 Non-Executive Chairman Executive Director and Chief Executive Of cer Executive Director and Chief Financial Of cer Chairman of the Nomination Committee Appointed as a Director 14 March 2005.
Also has Appointed as a Director 11 March 2004.
NonAppointed Chief Executive Of cer with effect from overall responsibility for Strategic Planning & Business Executive Chairman of Renault SA since April 2005.
Member of the Executive Board Development, Information Services and Global Chairman and Chief Executive Of cer of Renault SA of the Pharmaceutical Research and Manufacturers Purchasing.
Non-Executive Director of Diageo plc.
President of the Management Board of America PhRMA.
Board member of the Former member of the UK Accounting Standards of Renault-Nissan BV 2002-2005.
Chief Financial European Federation for Pharmaceutical Industries Board August 2003 August 2006.
Joint Chairman Of cer and Executive Vice-President 1988-1992 and and Associations EFPIA.
Executive Vice-President, of the Business Tax Forum.
Member of the Advisory President and Chief Operating Of cer 1990-1992, North America, AstraZeneca PLC 2001-2005.
Board of Oxford University Centre for Business Renault SA.
Non-Executive Director of BNP-Paribas, Chairman of the Board of the Southeastern Chapter Taxation.
Electricit fide France, Veolia Environnement, Volvo of the American Heart Association 2004-2006.
Vice-Chairman of the Supervisory Board of Philips Electronics NV.
MARCUS WALLENBERG 50 ERNA MLLER 66 JOHN VARLEY 50 Non-Executive Director Non-Executive Director Non-Executive Director Appointed as a Director 6 April 1999.
Formerly Member of the Remuneration Committee and the Member of the Remuneration Committee a Director of Astra AB appointed 18 May 1989.
Science Committee Appointed as a Director 26 July 2006.
Executive Stepped down from the Audit Committee on Appointed as a Director 6 April 1999.
Formerly Director of Barclays Bank plc and Barclays plc since 31 December 2005.
Chairman of Skandinaviska a Director of Astra AB appointed 15 May 1995.
1998 and Group Chief Executive since 2004.
Executive Director of the Knut and Alice Wallenberg of Ascot Authority Holdings since 2001.
President Vice-Chairman Telefonaktiebolaget LM Ericsson.
Professor of Clinical Immunology and of the Employers Forum on Disability and member Non-Executive Director of Electrolux AB, Stora Vice-Chairman of the Nobel Assembly, Karolinska of the International Advisory Panel of the Monetary Enso Oyj and the Knut and Alice Wallenberg Institutet.
Member of the Royal Swedish Academy Authority of Singapore.
Treasurer and Trustee of St. Foundation.
Chairman of International Chamber of Engineering Sciences and the Royal Swedish Dunstans, Trustee of Thornton Smith Plevins Young of Commerce ICC.
Peoples Trust and Chairman of Business Action on Homelessness.
JOHN BUCHANAN 63 JOE JIMENEZ 47 Non-Executive Director Non-Executive Director Chairman of the Audit Committee Member of the Remuneration Committee and Member of the Remuneration Committee.
and the Nomination Committee Appointed as a Director 25 April 2002.
Executive Appointed as a Director 1 July 2003.
Executive ViceDirector and Group Chief Financial Of cer of BP p. l. c. President of H J Heinz Company and President and 1996-2002.
Member of the UK Accounting Standards Chief Executive Of cer of Heinz Europe 2002-2006.
Senior Independent Director of Corporate Vice-President then Senior Vice-President BHP Billiton Plc.
Deputy Chairman of Vodafone and President of Heinz North America 1998-2002.
Chairman of Smith & Nephew plc.
Non-Executive Director of Blue Nile, Inc. 32 JOHN PATTERSON FRCP 58 HKAN MOGREN KBE 62 MICHELE HOOPER 55 Executive Director, Development Non-Executive Deputy Chairman Non-Executive Director Appointed as a Director 1 January 2005.
Fellow of Member of the Nomination Committee Member of the Audit Committee the Royal College of Physicians.
Director of the British Appointed as a Director 6 April 1999.
Formerly Appointed as a Director 1 July 2003.
Non-Executive Director of Cobham Chief Executive Of cer and a Director of Astra AB Chief Executive Of cer of Stadtlander Drug Company plc.
Non-Executive Director of Amersham plc 2001- appointed 18 May 1988.
President of the Association of the British of Directors of Investor AB, Rmy Cointreau SA, International Businesses of Caremark International Pharmaceutical Industry 2002-2004.
Member of Groupe Danone and Norsk Hydro ASA.
Non-Executive Director of PPG the Supervisory Board of the UK Medicines Control of the Marianne and Marcus Wallenberg Foundation.
Industries, Inc. Non-Executive Director of Warner Agency 1990-1994.
Executive Vice-President, Member of the Royal Swedish Academy of Music Group, Inc.
Product Strategy & Licensing and Business Engineering Sciences.
PROFESSOR DAME NANCY ROTHWELL 51 JANE HENNEY 59 SIR PETER BONFIELD CBE, FRENG 62 Non-Executive Director Non-Executive Director Senior Non-Executive Director Chairman of the Science Committee Member of the Audit Committee, the Nomination Chairman of the Remuneration Committee and Appointed as a Director 27 April 2006.
Also has Committee and the Science Committee Member of the Nomination Committee responsibility for overseeing Corporate Responsibility.
Fellow of MRC Research Professor and Vice-President for Currently Senior Vice-President and Provost for the Royal Academy of Engineering.
Non-Executive Research at the University of Manchester.
Trustee Health Affairs, University of Cincinnati Medical Director of Telefonaktiebolaget LM Ericsson, Mentor of Cancer Research UK and the Campaign for Medical Academic Health Center, appointed April 2003.
Graphics Corporation, Taiwan Semiconductor Progress, Chair of the Research Defence Society, Prior appointments include: Deputy Director, US Manufacturing Company, Ltd. Sony Corporation, Chair of the Wellcome Trust Public Engagement National Cancer Institute: Vice-Chancellor of Health, Japan and Actis Capital LLP.
Vice-President of The Strategy Panel.
Council member of the Biotechnology University of Kansas Medical Center: Deputy British Quality Foundation.
Member of the Citigroup and Biological Sciences Research Council.
Prior Commissioner for Operations, US Food and Drug International Advisory Board.
Member of the Sony appointments include: President of the British Administration: and Commissioner of Food and Corporation Advisory Board.
Chairman of NXP Neuroscience Association and Council member Drugs, US Food and Drug Administration.
Non-Executive Director, Corporate of the Medical Research Council.
Non-Executive Director of AmerisourceBergen Board of the Department for Constitutional Affairs.
Other board appointments include The Commonwealth Fund, China Medical Board, OMERIS and BIO START.
Other of cers of the Company at 31 December 2006 included members of the Senior Executive Team, as set out on pages 4 and 5, and: GRAEME MUSKER Group Secretary and Solicitor Appointed as Company Secretary 6 June 1993.
